The meteoric rise of Chinese start-up DeepSeek may have shaken Wall Street's confidence in some favorite trades, but it’s unlikely to change the immediate outlook for the spending that has fueled the ...

Goldman Sachs has hired Daniel Marcu from Amazon.com as its global head of artificial intelligence engineering and science to help develop and refine artificial intelligence platforms and products, ...

Stock traders took some risk off the table before the Federal Reserve decision, with a trio of tech heavyweights kicking off ...

But when it comes to fixing Goldman’s woman problem, the firm has not shown the same urgency. When Solomon became CEO, he claimed that promoting women into senior leadership was a priority. But now, ...

Microsoft (NASDAQ:MSFT) has lagged behind the NASDAQ over the past year but is off to a strong start in 2025, outperforming ...

Wednesday as Wall Street analysts hiked their price targets for the stock and bought into upbeat comments from Chief ...

Nvidia shares' 9% recovery Tuesday was the second-best day in terms of market cap added for any company ever, trailing only a ...

In a report shared with MarketWatch on Wednesday, the Goldman team, led by chief global equity strategist Peter Oppenheimer, said that while the buzz surrounding China's DeepSeek has raised questions ...

Tesla (NASDAQ:TSLA) will be under the Street’s microscope today with the EV giant slated to release 4Q24 results after the ...

As the global tech sector was catching up to the disruption caused by DeepSeek’s r1 AI model, Chinese e-commerce giant ...

Baird downgraded Leap Therapeutics (LPTX) to Neutral from Outperform with a price target of $1.25, down from $9, after the ...

Shares of vaccine maker Moderna Inc. fell Wednesday as Goldman Sachs lowered its rating after the biotech's second cut to product revenue guidance in six months. Moderna shares (MRNA) fell 2% in ...